Table 1 Results before and after the treatment.
From: A novel approach to the treatment of acuterenal failure associated with rhabdomyolysis
| Â | HP | CRRT + HP | ||||
|---|---|---|---|---|---|---|
| Â | T0 | T1 | Reduction | T0 | T1 | Reduction |
Creatinine (mg/dL) | 1,56 | 1,15 | 26,3% | 3,4 | 2,1 | 38,2% |
Myoglobin (ng/mL) | 18390 | 8359 | 54,6% | 52998 | 8862 | 83,3% |
Creatine Kinase (U/L) | - | - | - | 18587 | 8755 | 52,9% |